Editorial Board

Editors-in-Chief

Stephen Hanauer

University of Chicago, Chicago, IL, USA

Jack Satsangi

Western General Hospital, Edinburgh, UK

Editors
Federico Balzola
Azienda Ospedaliera San Giovanni Battista di Torino, Turin, Italy

Charles Bernstein
University of Manitoba, Winnipeg, MB, Canada

Gert Van Assche
University Hospital of Leuven, Leuven, Belgium

Editorial Advisory Board
Zane Cohen
Mount Sinai Hospital, Toronto, ON, Canada

Jean-Frédéric Colombel
Hôpital Huriez, Lille, France

Anders Ekbom
Karolinska Institute, Stockholm, Sweden

Brian Feagan
University of Western Ontario, London, ON, Canada

Claudio Fiocchi
Case Western Reserve University, Cleveland, OH, USA

John O’Leary
Coombe Women’s Hospital, Dublin, Ireland

Paul C Rutgeerts
Universitaire Ziekenhuizen Leuven, UZ Gasthuisberg, Leuven, Belgium

Ernest G Seidman
Hôpital Sainte-Justine, Université de Montréal, Montreal, QC, Canada

Stephan Targan
Cedars-Sinai Medical Center, Los Angeles, CA, USA

William J Tremaine
Mayo Clinic, Rochester, MN, USA

Good Publishing Practice

Instructions To Contributors

Editorial Policy

Editorial Policy
Inflammatory Bowel Disease Monitor is an independent journal published by Remedica Medical Education and Publishing Ltd. The aim is to provide an up-to-date overview of the recent literature compiled by an international team of practising physicians. Leading articles commissioned by the Editors-in-Chief review new therapeutic techniques and emerging technologies, and news from major international meetings is reported. Editorial control is vested entirely in the Editors-in-Chief, Editors, and Editorial Advisory Board.

Publisher’s Statement
© Remedica Medical Education and Publishing 2009. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the copyright owners. While every effort is made by the publishers and editorial board to see that no inaccurate or misleading data, opinions, or statements appear in this journal, they wish to make it clear that the material contained in the publication represents a summary of the independent evaluations and opinions of the authors and contributors. As a consequence, the board, publishers and any sponsoring company accept no responsibility for the consequences of any such inaccurate or misleading data or statements. Neither do they endorse the content of the publication or the use of any drug or device in a way that lies outside its current licensed application in any territory. For detailed information on any drugs or devices discussed in this publication, readers are advised to consult the Physicians Circular issued by the manufacturer.

Remedica Medical Education and Publishing Ltd., 1 New Oxford Street, London, WC1A 1NU
Telephone: +44 (0)20 7759 2999 Fax: +44 (0)20 7759 2951
Email: info@remedica.com

Managing Editor: Rhian Phillips
Editorial Assistant: Jessica Daniels
Editorial Manager: Scott Millar
Design and Artwork: AS&K Skylight Creative Services
Publishers: Ian Ackland-Snow, Simon Kirsch

ISSN 1466-7401 (Print)
ISSN 2040-3909 (Online)

Contact us at info@ibdmonitor.com